文献速递产科母胎医学

妊娠期使用低剂量阿司匹林可能是产后出血和失血量增加的一个潜在风险:一项系统评价和Meta分析

Low-dose asprin use during pregnancy may be a potential risk for postpartum hemorrhage and increased blood loss: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-01-25

该系统评价纳入21项研究共373,926名女性分析产后出血发生率,7项研究共10,163名女性分析产后失血量。妊娠期使用阿司匹林(每日60-150mg)与产后出血发生率升高相关(OR 1.20,95%CI 1.07-1.34),产后总失血量平均增加12.85 mL(95%CI 3.28-22.42)。结论认为低剂量阿司匹林是产后出血的潜在风险,临床医生需对此保持警觉。

要点

  • 妊娠期使用低剂量阿司匹林(每日60-150mg)与产后出血发生率升高相关(OR 1.20,95%CI 1.07-1.34)。
  • 仅纳入随机对照试验时,产后出血风险仍显著升高(OR 1.12,95%CI 1.00-1.25)。
  • 产后总失血量平均增加12.85 mL(95%CI 3.28-22.42)。

核心结论

  • 妊娠期使用低剂量阿司匹林是产后出血的潜在风险,并确实轻微增加产后失血量。
  • 在不否认阿司匹林综合价值的前提下,结论提醒临床医生关注使用阿司匹林孕妇的产后出血。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、Web of Science、Embase和Cochrane对照试验中心注册库,检索时间自建库至2022年10月。
  • 纳入比较妊娠期使用阿司匹林与安慰剂(或不使用阿司匹林)的研究,结局涵盖产后出血发生率或产后失血量。
  • 产后出血部分纳入21项研究共373,926名女性,产后失血量部分纳入7项研究共10,163名女性。
  • 采用随机效应模型进行Meta分析,同时进行随机对照试验与队列研究的合并分析以及仅随机对照试验的单独分析。

主要发现

  • 妊娠期使用阿司匹林(每日60-150mg)与产后出血发生率升高相关(OR 1.20,95%CI 1.07-1.34)。
  • 仅保留随机对照试验时,结果仍显著(OR 1.12,95%CI 1.00-1.25)。
  • 产后总失血量更高(平均差12.85 mL,95%CI 3.28-22.42)。
  • 排除队列研究后,产后失血量结果不变(平均差13.72 mL,95%CI 4.63-22.81)。
  • 结论更可能在发达国家中获得。

关键数值与推荐

  • 妊娠期使用阿司匹林(每日60-150mg)与产后出血发生率升高相关(OR 1.20,95%CI 1.07-1.34)。
  • 仅随机对照试验分析:产后出血OR 1.12(95%CI 1.00-1.25)。
  • 产后总失血量平均差12.85 mL(95%CI 3.28-22.42)。
  • 排除队列研究后产后失血量平均差13.72 mL(95%CI 4.63-22.81)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为结论提醒临床医生关注使用阿司匹林孕妇的产后出血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The association between aspirin use during pregnancy and the risk of postpartum hemorrhage remains unclear. This study aimed to explore the incidence of postpartum hemorrhage and the amount of postpartum blood loss among women who used aspirin during pregnancy. DATA SOURCES: From inception to October 2022, this study searched the following databases: MEDLINE, Web of Science, Embase, and the Cochrane Central Register of Controlled Trials. STUDY ELIGIBILITY CRITERIA: Studies comparing pregnancy outcomes that covered the incidence of postpartum hemorrhage or the amount of postpartum blood loss in pregnancies with aspirin vs placebo (or no aspirin) were included. METHODS: Reviewers separately ascertained studies, obtained data, and gauged study quality. The meta-analysis was conducted using a random effects model owing to the probable heterogeneity of the included studies. The rates of postpartum hemorrhage or the mean amounts of postpartum blood loss were compared, and the odds ratios or mean differences with 95% confidence intervals were estimated. Of note, 2 parts performed both a pooled analysis of randomized controlled trials and cohort studies and a separate analysis of randomized controlled trials. RESULTS: Overall, 21 studies with 373,926 women were included in the postpartum hemorrhage part, and 7 studies with 10,163 women were included in the postpartum blood loss part. The results suggested that aspirin (dose 60-150mg a day) use during pregnancy was associated with an increased incidence of postpartum hemorrhage (odds ratio, 1.20; 95% confidence interval, 1.07-1.34). When only randomized controlled trials were retained, the results remained significant (odds ratio, 1.12; 95% confidence interval, 1.00-1.25). In the second part, higher total blood loss after delivery was obtained (mean difference, 12.85 mL; 95% confidence interval, 3.28-22.42), and the result was unaltered when cohort studies were eliminated (mean difference, 13.72 mL; 95% confidence interval, 4.63-22.81). The conclusions are more likely to be obtained in developed countries. CONCLUSION: Low-dose aspirin use during pregnancy is a potential risk of postpartum hemorrhage and does slightly increase the amount of postpartum blood loss. Without denying the combined value of aspirin, our conclusions raised an alarm for clinicians about postpartum hemorrhage in women using aspirin during pregnancy.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Jiang Y, Chen Z, Chen Y, et al. Low-dose asprin use during pregnancy may be a potential risk for postpartum hemorrhage and increased blood loss: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 36706919. doi:10.1016/j.ajogmf.2023.100878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。